Trial Profile
A phase III study of Bicizar (C1 esterase inhibitor) in sepsis patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Nov 2015
Price :
$35
*
At a glance
- Drugs Complement C1 inhibitor protein (Primary)
- Indications Sepsis
- Focus Therapeutic Use
- 27 Nov 2015 New trial record